Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The exploration and development Company with projects in Greenland and Finland has entered into a Binding Head of Terms with USFM Corporation to fund $30m to earn 51% of the DiskoNuussuaq project in West Greenland.</li>
<li>80 Mile as the operator and will receive a management fee of 12.5% of the total expenditure as well as a £0.5m payment upon signing definitive agreements.</li>
<li>The new funds are to be directed towards drilling rather than reprocessing data with a minimum of $10m to be spent within 10 months of the signing. </li>
</ul>


The exploration and development Company with projects in Greenland and Finland has entered into a Binding Head of Terms with USFM Corporation to fund $30m to earn 51% of the DiskoNuussuaq project in West Greenland.
80 Mile as the operator and will receive a management fee of 12.5% of the total expenditure as well as a £0.5m payment upon signing definitive agreements.
The new funds are to be directed towards drilling rather than reprocessing data with a minimum of $10m to be spent within 10 months of the signing. 


Hybridan Small Cap Feast: 03 November 2025

External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Key points (machine generated)<ul><li>CVS Group PLC is a leading veterinary services provider in the U.K., focusing on consolidating independent practices.</li><li>A formal market investigation by the U.K. Competition and Markets Authority, set for March 2024, has led to a significant drop in investor confidence and stock price.</li><li>Despite a strong revenue growth rate, the stock trades at a lower multiple due to concerns over potential regulatory impacts on the company's strategy.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)CVS Group PLC is a leading veterinary services provider in the U.K., focusing on consolidating independent practices.A formal market investigation by the U.K. Competition and Markets Authority, set for March 2024, has led to a significant drop in investor confidence and stock price.Despite a strong revenue growth rate, the stock trades at a lower multiple due to concerns over potential regulatory impacts on the company's strategy.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Cvsg Group (CVSG.LSE) - Monday, Jul 7, 2025

Professional Special Situation Investor, TripleS Special Situation Investing

Triple S Special Situations Investing

Professional Special Situation Investor

TripleS Special Situation Investing

Professional Special Situation Investor with over 20 years of experience.

Event-Driven

<ul>
<li>
CVS Group plc (“CVSG”) has seen its share price take a hit recently, but the decline seems to stem from two short-term issues rather than any real damage to the business fundamentals.
</li>
<li>
The first blow came in March 2024 when the UK’s Competition and Markets Authority (CMA) unexpectedly announced a nationwide review of veterinary services for household pets.
</li>
<li>
These investigations typically last 12 to 18 months, so we’re looking at a resolution by late 2025 with a mid term resolution being around the corner mid-year.
</li>
</ul>



CVS Group plc (“CVSG”) has seen its share price take a hit recently, but the decline seems to stem from two short-term issues rather than any real damage to the business fundamentals.


The first blow came in March 2024 when the UK’s Competition and Markets Authority (CMA) unexpectedly announced a nationwide review of veterinary services for household pets.


These investigations typically last 12 to 18 months, so we’re looking at a resolution by late 2025 with a mid term resolution being around the corner mid-year.



Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Crude oil prices display bullish short-term reversals, resulting in bullish price and RS reversals for global Energy stocks -- add exposure. From a macro perspective, despite some mild price deterioration recently on major indexes around the globe, our outlook remains unchanged and we remain neutral yet constructive overall. Market dynamics remain largely constructive and we continue to see attractive opportunities in many countries/regions such as Japan, China (Shanghai Composite), Europe, India, and Canada, to name a few.

Crude oil prices display bullish short-term reversals, resulting in bullish price and RS reversals for global Energy stocks -- add exposure. From a macro perspective, despite some mild price deterioration recently on major indexes around the globe, our outlook remains unchanged and we remain neutral yet constructive overall. Market dynamics remain largely constructive and we continue to see attractive opportunities in many countries/regions such as Japan, China (Shanghai Composite), Europe, India, and Canada, to name a few.

Global Energy Sector Improving -- Buying Reliance Industries Ltd, Several Others

United Kingdom

CVS Group PLC provides animal veterinary and related services. The Company sells animal medicines and a range of pet products directly to consumers. CVS Group operates throughout the United Kingdom.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CVS Group PLC (CVSG LN)

Hybridan Small Cap Feast: 03 November 2025

0 Mile as the operator and will receive a management fee of 12.5% of the total expenditure as well as a £0.5m payment upon signing definitive...

Hybridan

Cvsg Group (CVSG.LSE) - Monday, Jul 7, 2025

CVS Group PLC faces declining investor confidence and a stock drop from £21.00 to £9.00 amid a CMA investigation, raising concerns over its...

Value Investors Club (VIC)

CVSG: A Special Sit with 2x Potential

CVS Group plc (“CVSG”) has seen its share price take a hit recently, but the decline seems to stem from two short-term issues rather than any real...

Triple S Special Situations Investing

Global Energy Sector Improving -- Buying Reliance Industries Ltd, Several Others

Crude oil prices display bullish short-term reversals, resulting in bullish price and RS reversals for global Energy stocks -- add exposure.

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)